Measurement of serum hyaluronic acid as a sensitive marker of liver fibrosis in biliary atresia

被引:29
作者
Hasegawa, T
Sasaki, T
Kimura, T
Hoki, M
Okada, A
Mushiake, S
Yagi, M
Imura, K
机构
[1] Osaka Univ, Sch Med, Dept Pediat Surg, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan
[3] Osaka Med Ctr Maternal & Child Hlth, Dept Pediat Surg, Osaka, Japan
关键词
biliary atresia; liver fibrosis; cirrhosis; hyaluronic acid; serum marker;
D O I
10.1053/jpsu.2000.18342
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Purpose: The aim of this study was to clarify whether serum hyaluronic acid level (SHA) can reflect the degree of liver fibrosis in biliary atresia (BA). Methods: SHA was measured in 44 postoperative BA patients at 7 months to 22 years of age, with sandwich enzyme method (Hy-A 100 kit). SHA was compared with T.Bil (group 1,T Sil < 2; group 2, 2 <less than or equal to> Bil T < 5; group 3, T Bil <greater than or equal to> 5 mg/dL), fibrosis score (0-6, the number of abnormal values among Alb, PT, ChE, T Chol, Fischer's ratio, prealbumin), and histologic grading (0-IV). Results: SHA was 499.8 +/- 332.5 in group 3, significantly higher than in the control, group 1, or group 2. As fibrosis score rose, SHA became higher, and SHA in Score 6 (430.1 +/- 366.1 ng/mL) and score-5 (172.9 +/- 141.8 ng/mL) was significantly higher than in the control and other scores, respectively. As the histologic grade rose, SHA became higher, and SHA in grade IV (444.8 +/- 323.5 ng/mL) and grade III (166.0 +/- 70.3 ng/mL) was significantly higher than in the control or other Grades. Serial change of SHA since before HPE was parallel to the clinical course in 8 patients. Conclusion: SHA may be a useful serum marker reflecting the degree of liver fibrosis in BA. Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:1643 / 1646
页数:4
相关论文
共 30 条
[1]   ELEVATED LEVELS OF PLASMA HYALURONAN IN SEPTICEMIA [J].
BERG, S ;
BRODIN, B ;
HESSELVIK, F ;
LAURENT, TC ;
MALLER, R .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1988, 48 (08) :727-732
[2]   SERUM HYALURONATE AS A MARKER OF HEPATIC DERANGEMENT IN ACUTE LIVER-DAMAGE [J].
BRAMLEY, PN ;
RATHBONE, BJ ;
FORBES, MA ;
COOPER, EH ;
LOSOWSKY, MS .
JOURNAL OF HEPATOLOGY, 1991, 13 (01) :8-13
[3]   ASSAY OF SERUM HYALURONIC-ACID IN CLINICAL-APPLICATION [J].
CHICHIBU, K ;
MATSUURA, T ;
SHICHIJO, S ;
YOKOYAMA, MM .
CLINICA CHIMICA ACTA, 1989, 181 (03) :317-323
[4]  
DAHL IMS, 1988, CANCER-AM CANCER SOC, V62, P326, DOI 10.1002/1097-0142(19880715)62:2<326::AID-CNCR2820620217>3.0.CO
[5]  
2-Y
[6]   Biliary atresia: The King's College Hospital experience (1974-1995) [J].
Davenport, M ;
Kerkar, N ;
MieliVergani, G ;
Mowat, AP ;
Howard, ER .
JOURNAL OF PEDIATRIC SURGERY, 1997, 32 (03) :479-485
[7]   CIRCULATING HYALURONATE IN RHEUMATOID-ARTHRITIS - RELATIONSHIP TO INFLAMMATORY ACTIVITY AND THE EFFECT OF CORTICOSTEROID-THERAPY [J].
ENGSTROMLAURENT, A ;
HALLGREN, R .
ANNALS OF THE RHEUMATIC DISEASES, 1985, 44 (02) :83-88
[8]   HISTOLOGICAL LIVER EVALUATION 5 YEARS AFTER SURGERY FOR EXTRAHEPATIC BILIARY ATRESIA - A STUDY OF 20 CASES [J].
GAUTIER, M ;
VALAYER, J ;
ODIEVRE, M ;
ALAGILLE, D .
JOURNAL OF PEDIATRIC SURGERY, 1984, 19 (03) :263-268
[9]   HEMODYNAMIC AND LIVER-FUNCTION PREDICTORS OF SERUM HYALURONAN IN ALCOHOLIC LIVER-DISEASE [J].
GIBSON, PR ;
FRASER, JRE ;
BROWN, TJ ;
FINCH, CF ;
JONES, PA ;
COLMAN, JC ;
DUDLEY, FJ .
HEPATOLOGY, 1992, 15 (06) :1054-1059
[10]   ULTRASONIC DIAGNOSIS OF CIRRHOSIS - REFERENCE TO QUANTITATIVE MEASUREMENTS OF HEPATIC DIMENSIONS [J].
GOYAL, AK ;
POKHARNA, DS ;
SHARMA, SK .
GASTROINTESTINAL RADIOLOGY, 1990, 15 (01) :32-34